Evidence map›Paper›PMID 40046883›Full record

ArticleOpen forum infectious diseases2025

Enhanced

Isabella C Auchus, Joelle Brown, Mike Kama, Sara G Vargo, Rachel Devi, Jenni Singh, Deborah Dean

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Isabella C AuchusDepartment of Pediatrics, University of California, San Francisco, San Francisco, California, USA.ORCID https://orcid.org/0000-0003-2918-6606
Joelle BrownDepartment of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA.ORCID https://orcid.org/0000-0002-6044-2906
Mike KamaDepartment of Public Health, Ministry of Health and Medical Services, Suva, Fiji.
Sara G VargoDepartment of Pediatrics, University of California, San Francisco, San Francisco, California, USA.ORCID https://orcid.org/0009-0000-1085-1368
Rachel DeviDepartment of Family Health, Ministry of Health and Medical Services, Suva, Fiji.
Jenni SinghSexual and Reproductive Health, Ministry of Health and Medical Services, Suva, Fiji.
Deborah DeanDepartment of Pediatrics, University of California, San Francisco, San Francisco, California, USA.ORCID https://orcid.org/0000-0002-4490-1746

Funding

Natural History of C. trachomatis urogenital and rectal infectionsR01AI151075 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DEAN, DEBORAH ANNE, READ, TIMOTHY D. · 2020 to 2024
$4.0M
NIAID NIH HHS R01 AI151075
6 · The paper itself

Abstract

Background: The coronavirus disease 2019 pandemic impact on sexually transmitted infections in countries practicing syndromic management remains unknown. We conducted cross-sectional surveys in Fiji to assess increases and risk factors for Methods: We enrolled women, men who have sex only with women (MSW), and men who have sex with men (MSM) aged 18-40 years, collected sociodemographic/behavioral data, and tested vaginal, urethral, and rectal samples using Xpert-CT/NG. Risk factors were evaluated using regression models. Results: Of 1955 participants, 6.4% (95% confidence interval [CI], 5.4%-7.6%) had gonorrhea, increasing significantly postpandemic >2-fold among women aged 25-40 years and >4-fold among MSM, MSW, and men aged 18-24 and 25-40 years; 20.0% (95% CI, 18.3%-21.8%) had chlamydia, increasing significantly postpandemic among younger women and approximately 2- to 4-fold among MSW and younger and older men. Increases were driven by urethral/vaginal infections. Coinfections increased significantly postpandemic among older women. Postpandemic gonorrhea was associated with difficulty obtaining condoms (adjusted relative risk [aRR], 2.7 [95% CI, 1.0-8.0]) and ≥2 partners (aRR, 2.6 [95% CI, 1.0-7.1]) among younger women, and iTaukei ethnicity (aRR, 4.7 [95% CI, 1.4-16.5]) and heavy alcohol use (aRR, 7.1 [95% CI, 2.5-19.7]) among older women. Postpandemic chlamydia was associated with having a casual sex partner among younger (aRR, 1.7 [95% CI, 1.0-2.9]) and older (aRR, 1.9 [95% CI, 1.1-3.4]) women and with being unmarried (aRR, 1.7 [95% CI, 1.0-2.7]). iTaukei men had increased risk postpandemic for gonorrhea (aRR, 3.7 [95% CI, 1.3-10.6]) and chlamydia (aRR, 2.5 [95% CI, 1.3-4.9]). More than 50% of infected participants did not meet syndromic treatment criteria and would have remained untreated. Conclusions: Postpandemic increases in gonorrhea and chlamydia-with risk factors varying by pathogen, gender, and age-require immediate interventions to reduce infection and transmission in Fiji.

Indexed as

Chlamydia trachomatisCOVID-19 pandemicFijiNeisseria gonorrhoeaePacific Islanders

Identifiers

PMID40046883
PMCPMC11881064

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.